Finzati - Logo
KPTI logo

Karyopharm Therapeutics Inc.

KPTIBiotechnology
$1.79
+0.02 (+1.13%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$51.80M
Growth
44.6%
Cash Flow
0/5
Trend
Negative
Evidence
Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:31 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.79
Change1.13%
Shares Out28.94M
Market Cap$51.80M
Enterprise Value$12.63M
52W Range1.80 - 10.99
Beta0.95
P/E-0.23
P/S0.35
P/B-0.16
P/FCF-0.79
EV/Sales0.09

Investment DNA

How strong this company looks for long-term investors

39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
49/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score
Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

KPTI
Analyst sentiment
Based on 20 analyst votes · 2026-09-05
78/100
Bullish
Bullish
13
Hold
5
Bearish
2
Price Target
2026-08-14
Low
$3.00
Mean
$13.20
Median
$16.00
High
$28.00

Company Overview

IPO: 11/6/2013
Industry: Biotechnology
P/B i: -0.16
Debt / Equity i: -0.80
Operating Margin: -62.10%
Net Margin: -134.21%
ROE i: -
ROIC: -

Financial Health

Score10 / 20
Debt / Equity: -0.80
Current Ratio: 1.12
Quick Ratio: 1.08
Status: Moderate

Insider Transactions

Recent executive and insider activity

Poulton Stuart
Transaction: 07/28/2026
SELL
Change
-189
Price
$7.10
Filing
07/30/2026
Type
SELL
Greene Barry E
Transaction: 05/21/2026
BUY
Change
+15,508
Price
Not reported
Filing
05/26/2026
Type
BUY
BOHLIN GAREN G
Transaction: 05/21/2026
BUY
Change
+15,508
Price
Not reported
Filing
05/26/2026
Type
BUY